GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (HAM:IP4) » Definitions » Payments of Debt

InnoCan Pharma (HAM:IP4) Payments of Debt : €-0.02 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is InnoCan Pharma Payments of Debt?

InnoCan Pharma's Payments of Debt for the three months ended in Dec. 2023 was €-0.01 Mil.

InnoCan Pharma's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.02 Mil.


InnoCan Pharma Payments of Debt Historical Data

The historical data trend for InnoCan Pharma's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Payments of Debt Chart

InnoCan Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial -0.03 -0.03 -0.03 -0.01 -0.02

InnoCan Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 -0.01 -0.01 -0.01

InnoCan Pharma Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnoCan Pharma Payments of Debt Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


InnoCan Pharma (HAM:IP4) Business Description

Traded in Other Exchanges
Address
1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (HAM:IP4) Headlines

No Headlines